By Josh Beckerman
Certara Inc. shares fell 15% to $17.24 after the biosimulation company said certain stockholders including EQT AB plan to sell 7 million shares.
On Tuesday, Certara said second-quarter revenue rose 18% to $82.8 million, but added that it expects foreign exchange impact and softness in regulatory services to continue in the second half of the year.
Write to Josh Beckerman at josh.beckerman@wsj.com
Read the full article here
